Switch theme
Sign up to access all valuation multiples
MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has three reporting segments: ANZ Operations, U.S. Operations and UK Operations. The company derives majority of its revenues from U.S. Operations.
2010
n/a
LTM Revenue $62.3M
LTM EBITDA -$1.9M
$40.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MedAdvisor has a last 12-month revenue (LTM) of $62.3M and a last 12-month EBITDA of -$1.9M.
In the most recent fiscal year, MedAdvisor achieved revenue of $78.4M and an EBITDA of $4.5M.
MedAdvisor expects next 12-month revenue of XXX and NTM EBITDA of XXX
See MedAdvisor valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $62.3M | XXX | $78.4M | XXX | XXX | XXX |
| Gross Profit | $38.6M | XXX | $47.7M | XXX | XXX | XXX |
| Gross Margin | 62% | XXX | 61% | XXX | XXX | XXX |
| EBITDA | -$1.9M | XXX | $4.5M | XXX | XXX | XXX |
| EBITDA Margin | -3% | XXX | 6% | XXX | XXX | XXX |
| EBIT | -$4.3M | XXX | $1.7M | XXX | XXX | XXX |
| EBIT Margin | -7% | XXX | 2% | XXX | XXX | XXX |
| Net Profit | -$6.2M | XXX | $0.5M | XXX | XXX | XXX |
| Net Margin | -10% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, MedAdvisor's stock price is AUD 0 (or $0).
MedAdvisor has current market cap of AUD 56.9M (or $36.5M), and EV of AUD 63.4M (or $40.7M).
See MedAdvisor trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $40.7M | $36.5M | XXX | XXX | XXX | XXX | $-0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, MedAdvisor has market cap of $36.5M and EV of $40.7M.
MedAdvisor's trades at 0.6x EV/Revenue multiple, and 39.0x EV/EBITDA.
Equity research analysts estimate MedAdvisor's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
MedAdvisor has a P/E ratio of -5.9x.
See valuation multiples for MedAdvisor and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $36.5M | XXX | $36.5M | XXX | XXX | XXX |
| EV (current) | $40.7M | XXX | $40.7M | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | -21.7x | XXX | 39.0x | XXX | XXX | XXX |
| EV/EBIT | -9.5x | XXX | -26.4x | XXX | XXX | XXX |
| EV/Gross Profit | 1.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | -5.9x | XXX | -11.7x | XXX | XXX | XXX |
| EV/FCF | -5.6x | XXX | -13.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMedAdvisor's last 12 month revenue growth is 9%
MedAdvisor's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
MedAdvisor's rule of 40 is 11% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
MedAdvisor's rule of X is 21% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for MedAdvisor and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | -3% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Growth | -342% | XXX | 3% | XXX | XXX | XXX |
| Rule of 40 | 11% | XXX | 11% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 21% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 59% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MedAdvisor acquired XXX companies to date.
Last acquisition by MedAdvisor was XXXXXXXX, XXXXX XXXXX XXXXXX . MedAdvisor acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was MedAdvisor founded? | MedAdvisor was founded in 2010. |
| Where is MedAdvisor headquartered? | MedAdvisor is headquartered in Australia. |
| Is MedAdvisor publicy listed? | Yes, MedAdvisor is a public company listed on ASX. |
| What is the stock symbol of MedAdvisor? | MedAdvisor trades under MDR ticker. |
| When did MedAdvisor go public? | MedAdvisor went public in 2011. |
| Who are competitors of MedAdvisor? | Similar companies to MedAdvisor include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of MedAdvisor? | MedAdvisor's current market cap is $36.5M |
| What is the current revenue of MedAdvisor? | MedAdvisor's last 12 months revenue is $62.3M. |
| What is the current revenue growth of MedAdvisor? | MedAdvisor revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of MedAdvisor? | Current revenue multiple of MedAdvisor is 0.7x. |
| Is MedAdvisor profitable? | Yes, MedAdvisor is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of MedAdvisor? | MedAdvisor's last 12 months EBITDA is -$1.9M. |
| What is MedAdvisor's EBITDA margin? | MedAdvisor's last 12 months EBITDA margin is -3%. |
| What is the current EV/EBITDA multiple of MedAdvisor? | Current EBITDA multiple of MedAdvisor is -21.7x. |
| What is the current FCF of MedAdvisor? | MedAdvisor's last 12 months FCF is -$7.2M. |
| What is MedAdvisor's FCF margin? | MedAdvisor's last 12 months FCF margin is -12%. |
| What is the current EV/FCF multiple of MedAdvisor? | Current FCF multiple of MedAdvisor is -5.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
